Nektar Therapeutics
NKTR
#4201
Rank
S$3.66 B
Marketcap
S$108.68
Share price
1.89%
Change (1 day)
714.82%
Change (1 year)

EPS for Nektar Therapeutics (NKTR)

EPS in 2025 (TTM): S-$5.56

According to Nektar Therapeutics 's latest financial reports the company's current EPS (TTM) is S-$5.36. In 2024 the company made an earnings per share (EPS) of S-$4.44 an increase over its 2023 EPS that were of S-$27.76.

EPS history for Nektar Therapeutics from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S-$5.5625.34%
2024S-$4.44-84.02%
2023S-$27.76-25.89%
2022S-$37.45-31.12%
2021S-$54.3714.86%
2020S-$47.34-1.19%
2019S-$47.91-163.96%
2018S$74.90-725.4%
2017S-$11.98-42.73%
2016S-$20.9183.33%
2015S-$11.4139.53%
2014S-$8.17-69.29%
2013S-$26.62-6.67%
2012S-$28.52

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$14.12-363.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$1.72-132.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$18.16-438.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
S-$2.34-56.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$9.27-272.82%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$7.52-240.19%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
S$0.08872-101.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
S$2.62-148.94%๐Ÿ‡ฎ๐Ÿ‡ช Ireland